LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Smart Hydrogel Paves Way for New ‘Lollipop’ Mouth Cancer Diagnostic

By LabMedica International staff writers
Posted on 25 Mar 2024
Print article
Image: The potentially flavored ‘lollipop’ could help mouth cancer diagnosis (Photo courtesy of University of Birmingham)
Image: The potentially flavored ‘lollipop’ could help mouth cancer diagnosis (Photo courtesy of University of Birmingham)

Currently, the process of diagnosing oral cancer involves the uncomfortable step of inserting a flexible camera, attached to a tube, through the nose or mouth to take a tissue sample. This invasive procedure, which is both time-consuming and reliant on skilled professionals, could soon be replaced by a groundbreaking and patient-friendly alternative. A newly developed 'lollipop' diagnostic tool, created using innovative smart hydrogel technology, promises a quicker, more accurate, and less invasive way to diagnose mouth cancer, potentially leading to earlier detection for patients.

Researchers from the University of Birmingham (Birmingham, UK) are developing a prototype flavored ‘lollipop’ from a smart hydrogel they had developed previously. Smart hydrogels have a remarkable ability to soak up vast amounts of water while capturing larger molecules, like proteins, similar to how a net captures fish. This innovative diagnostic tool works by having patients transfer saliva into the hydrogel by sucking on the 'lollipop.' Subsequently, proteins indicative of the early stages of mouth cancer can be isolated by exposing the hydrogel to UV light, releasing the captured proteins for laboratory analysis. The biocompatible hydrogel concentrates and labels proteins with a fluorescent marker in just one step, making it ideal for diagnostics that aim to detect low-abundance proteins from small samples.

The hydrogel achieves protein capture via the fluorescent marker (fluorescein isothiocyanate or FITC), which is attached to the hydrogel by a photocleavable bond. Upon exposure to light, the protein, which is now attached to the fluorescein, gets released from the hydrogel. Early experiments demonstrated the hydrogel's ability to offer a concentration factor of 236 with a reference protein (streptavidin), and 50% of the proteins in the hydrogel were released after 100 seconds of exposure to UV light. This gel presents several advantages over current diagnostic methods by simplifying the process, requiring fewer steps than ELISA-based assays or preconcentration techniques, and operating effectively at room temperature. Its biocompatibility further allows for its application both in vitro and directly on patients, marking a significant advancement from traditional, invasive diagnostic procedures that demand medical expertise.

“Smart hydrogels have really exciting potential for diagnosing mouth cancer,” said Dr. Ruchi Gupta, Associate Professor of Biosensors at the University of Birmingham who developed the gel. “They can be easily molded into shapes as a solid to “catch” proteins in saliva, and we’re hoping that we can be the first to make a device which is much kinder for diagnosing mouth cancer for patients and easier for GPs to use.”

Related Links:
University of Birmingham

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more